Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick E Hubbard

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.
ACS Omega|September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its AnaloguesSzabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 15, 2023
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensorsEdward A FitzGerald, Darius Vagrys, Giulia Opassi, et al.
ACS Chemical Neuroscience|January 18, 2024
Identification of a Novel Subtype-Selective α<sub>1B</sub>-Adrenoceptor AntagonistAlaa Abdul-Ridha, Lazarus A de Zhang, Ashenafi Haileyesus Betrie, et al.
RSC Medicinal Chemistry|December 22, 2022
Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinatesS Paul Jones, James D Firth, Mary C Wheldon, et al.
Journal of Medicinal Chemistry|October 23, 2024
Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo ActivityAttila Vasas, Lisa Ivanschitz, Balázs Molnár, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2007
Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scopingChristine M Richardson, Claire L Nunns, Douglas S Williamson, et al.
ACS Omega|January 26, 2026
Targeting PTPN22 at Nonorthosteric Binding SitesA Fragment ApproachPaola Di Lello, Marta M Wells, Ben Davis, et al.
RSC Medicinal Chemistry|November 25, 2022
PAC-FragmentDEL - photoactivated covalent capture of DNA-encoded fragments for hit discoveryHuiyong Ma, James B Murray, Huadong Luo, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.
ACS Omega|September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its AnaloguesSzabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.
SLAS Discovery : Advancing Life Sciences R & D|September 15, 2023
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensorsEdward A FitzGerald, Darius Vagrys, Giulia Opassi, et al.
ACS Chemical Neuroscience|January 18, 2024
Identification of a Novel Subtype-Selective α<sub>1B</sub>-Adrenoceptor AntagonistAlaa Abdul-Ridha, Lazarus A de Zhang, Ashenafi Haileyesus Betrie, et al.
RSC Medicinal Chemistry|December 22, 2022
Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinatesS Paul Jones, James D Firth, Mary C Wheldon, et al.
Journal of Medicinal Chemistry|October 23, 2024
Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo ActivityAttila Vasas, Lisa Ivanschitz, Balázs Molnár, et al.
Bioorganic & Medicinal Chemistry Letters|June 16, 2007
Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scopingChristine M Richardson, Claire L Nunns, Douglas S Williamson, et al.
ACS Omega|January 26, 2026
Targeting PTPN22 at Nonorthosteric Binding SitesA Fragment ApproachPaola Di Lello, Marta M Wells, Ben Davis, et al.
RSC Medicinal Chemistry|November 25, 2022
PAC-FragmentDEL - photoactivated covalent capture of DNA-encoded fragments for hit discoveryHuiyong Ma, James B Murray, Huadong Luo, et al.
Pageof 8